Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Gelisken
Faik
F
Ziemssen
Focke
F
Voelker
Michael
M
Bartz-Schmidt
Karl U
KU
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D005122:Exudates and Transudates; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D008268:Macular Degeneration / Q000150:complications / Q000188:drug therapy*; D010857:Pigment Epithelium of Eye / Q000187:drug effects* / Q000473:pathology; D012167:Retinal Perforations / Q000139:chemically induced* / Q000175:diagnosis; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab